BofA: Investors pour into bonds, pull back from crypto
Investing.com -- Shares of Owens & Minor Inc (NYSE:OMI) soared over 10% following the announcement that the company has mutually agreed with Rotech Healthcare Holdings Inc. to terminate their previously planned acquisition. The healthcare solutions company has paid a termination fee of $80 million to Rotech Healthcare and will redeem the $1 billion of notes issued with an April 2025 maturity date, which included a special mandatory redemption provision.
The termination of the deal comes after extensive efforts to gain regulatory approval were deemed unfeasible by Owens & Minor in terms of time, expense, and opportunity costs. Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor, expressed confidence in the company’s strategy despite the setback, emphasizing the intention to grow their Patient Direct business and focus on improving cash flow for deleveraging purposes.
The healthcare market, especially home-based care for chronic conditions, continues to be a dynamic growth area for Owens & Minor. The company also mentioned ongoing discussions regarding the potential sale of its Products and Healthcare Services (NASDAQ:HCSG) business, indicating efforts to strengthen and capitalize on this segment’s potential.
Investors responded positively to the news, likely interpreting the canceled acquisition and the strategic focus on internal growth and debt reduction as beneficial for the company’s financial health and long-term strategy. The stock’s significant rise reflects this sentiment, as Owens & Minor reassures stakeholders of its commitment to profitable growth and a stronger balance sheet.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.